Search

Your search keyword '"Merck Sharp & Dohme Corp. -- Intellectual property"' showing total 44 results

Search Constraints

Start Over You searched for: Descriptor "Merck Sharp & Dohme Corp. -- Intellectual property" Remove constraint Descriptor: "Merck Sharp & Dohme Corp. -- Intellectual property" Journal obesity, fitness & wellness week Remove constraint Journal: obesity, fitness & wellness week
44 results on '"Merck Sharp & Dohme Corp. -- Intellectual property"'

Search Results

1. Researchers Submit Patent Application, 'Tricyclic Heterocycle Compounds Useful As Hiv Integrase Inhibitors', for Approval (USPTO 20210361662)

2. Researchers Submit Patent Application, 'Formulations Of Anti-Rsv Antibodies And Methods Of Use Thereof', for Approval (USPTO 20210324052)

3. Patent Issued for Prefilled disposable injection device (USPTO 11123499)

4. Researchers Submit Patent Application, 'Inhibitors Of Histone Deacetylase Useful For The Treatment Or Prevention Of Hiv Infection', for Approval (USPTO 20210276992)

5. Patent Issued for Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase (USPTO 11096930)

6. Patent Issued for 5-alkyl pyrrolidine orexin receptor agonists (USPTO 11098029)

7. Patent Issued for Anti-LAG3 antibodies and antigen-binding fragments (USPTO 11045547)

8. Patent Application Titled 'Combinations of PD-1 Antagonists and Benzo[b]thiophene STING Agonists for Cancer Treatment' Published Online (USPTO 20210130466)

9. Researchers Submit Patent Application, 'Tyrosine-Specific Functionalized Insulin And Insulin Analogs', for Approval (USPTO 20210002345)

10. Researchers Submit Patent Application, 'Pharmaceutical Compositions Of Tedizolid Phosphate', for Approval (USPTO 20200360360)

13. Patent Application Titled 'Pharmaceutical Compositions Containing Doravirine, Tenofovir Disoproxil Fumarate And Lamivudine' Published Online (USPTO 20200179291)

15. Patent Issued for Process For Making Chloro-Substituted Nucleoside Phosphoramidate Compounds (USPTO 10,597,422)

16. Patent Issued for Prefilled Disposable Injection Device (USPTO 10,543,317)

17. Patent Issued for Prefilled Disposable Injection Device (USPTO 10,500,338)

18. Patent Issued for Pegylated Interleukin-10 (USPTO 10,471,126)

19. Patent Issued for Process For Preparing Beta-Lactamase Inhibitor Hydroxylurea Intermediates (USPTO 10,464,937)

20. Researchers Submit Patent Application, 'Process For Preparing Beta-Lactamase Inhibitor Hydroxylurea Intermediates', for Approval (USPTO 20190233421)

21. Patent Issued for Preparation And Use Of 7a-Heterocycle Substituted-6,6-Difluoro Bicyclic Himbacine Derivatives As PAR-1 Receptor Antagonists (USPTO 10,322,140)

22. Patent Issued for 7-Aminocephem Derivative Compounds (USPTO 10,308,666)

23. Patent Issued for Liquid Formulations for an anti-TNF .Alpha. Antibody (USPTO 9844594)

24. Patent Issued for Pharmaceutical Formulation Comprising Losartan Potassium and Chlorthalidone (USPTO 9820973)

25. Patent Issued for Method of Treating Non-Small-Cell Lung Cancer Using Pharmaceutical Formulation Containing Thienotriazolodiazepine Compounds (USPTO 9820992)

26. Patent Issued for Methods for Treating Intrapulmonary Infections (USPTO 9724353)

27. Patent Issued for Solid Pharmaceutical Compositions Containing an Integrase Inhibitor (USPTO 9649311)

28. Patent Issued for Gamma Secretase Modulators (USPTO 9598437)

29. Patent Issued for Mineralocorticoid Receptor Antagonists (USPTO 9505730)

30. Patent Issued for Mineralocorticoid Receptor Antagonists (USPTO 9487506)

31. Patent Application Titled 'Media Milling Process for the Manufacture of Active Pharmaceutical Ingredients in Propellants' Published Online (USPTO 20160317391)

32. Patent Issued for Spirocyclic Sulfones as Gamma Secretase Inhibitors (USPTO 9464103)

33. Patent Issued for Enolase Peptide Conjugate Vaccines against Staphylococcus Aureus (USPTO 9447403)

34. Patent Issued for Preparation of Crystalline Forms of Dihydropyrazolopyrimidinone (USPTO 9388186)

35. Patent Issued for Process and Intermediates for Preparing Macrolactams (USPTO 9238604)

36. Researchers Submit Patent Application, 'LIQUID FORMULATIONS FOR TNFR:Fc FUSION PROTEINS', for Approval (USPTO 20150290325)

37. Patent Issued for Inhibitors of the Renal Outer Medullary Potassium Channel (USPTO 9108947)

38. Patent Issued for Pyrazolo[1,5-A]pyrimidines as Mark Inhibitors

39. Patent Issued for Pyrimidine Ether Derivatives and Methods of Use

40. Patent Issued for Fused Tricyclic Compounds for the Treatment of Inflammatory Disorders

41. Patent Issued for Imidazo[1,2-A]pyridines and Imidazo[1,2-B]pyridazines as Mark Inhibitors

43. Patent Issued for Bicyclic Heterocycle Derivatives and Methods of Use

44. Patent Issued for Method of Treatment Using Fatty Acid Synthesis Inhibitors

Catalog

Books, media, physical & digital resources